Bank of Montreal’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $183K | Sell |
10,185
-15,630
| -61% | -$296K | ﹤0.01% | 3042 |
|
|
2026
Q1 | $562K | Buy |
25,815
+10,685
| +71% | +$207K | ﹤0.01% | 2339 |
|
|
2025
Q4 | $326K | Buy |
15,130
+2,279
| +18% | +$48K | ﹤0.01% | 2541 |
|
|
2025
Q3 | $248K | Sell |
12,851
-26,745
| -68% | -$477K | ﹤0.01% | 2646 |
|
|
2025
Q2 | $677K | Sell |
39,596
-110,514
| -74% | -$4.71M | ﹤0.01% | 2106 |
|
|
2025
Q1 | $9.58M | Sell |
150,110
-6,308
| -4% | -$664K | ﹤0.01% | 944 |
|
|
2024
Q4 | $19M | Sell |
156,418
-29,174
| -16% | -$3.58M | 0.01% | 766 |
|
|
2024
Q3 | $23.1M | Buy |
185,592
+7,702
| +4% | +$1.06M | 0.01% | 726 |
|
|
2024
Q2 | $29.6M | Buy |
177,890
+1,050
| +0.6% | +$135K | 0.01% | 634 |
|
|
2024
Q1 | $23.1M | Buy |
176,840
+24,290
| +16% | +$2.98M | 0.01% | 689 |
|
|
2023
Q4 | $14.9M | Sell |
152,550
-119,663
| -44% | -$11.5M | ﹤0.01% | 885 |
|
|
2023
Q3 | $32.5M | Buy |
272,213
+174,299
| +178% | +$19.7M | 0.01% | 557 |
|
|
2023
Q2 | $12.9M | Buy |
97,914
+62,921
| +180% | +$8.11M | ﹤0.01% | 915 |
|
|
2023
Q1 | $4.83M | Sell |
34,993
-20,356
| -37% | -$2.64M | ﹤0.01% | 1250 |
|
|
2022
Q4 | $7.31M | Sell |
55,349
-4,755
| -8% | -$551K | ﹤0.01% | 1114 |
|
|
2022
Q3 | $6.76K | Sell |
60,104
-47,492
| -44% | -$4.79M | ﹤0.01% | 1193 |
|
|
2022
Q2 | $8.15K | Sell |
107,596
-373,770
| -78% | -$27.5M | ﹤0.01% | 1157 |
|
|
2022
Q1 | $37.8M | Buy |
481,366
+460,768
| +2,237% | +$35.3M | 0.02% | 568 |
|
|
2021
Q4 | $1.87M | Sell |
20,598
-261,711
| -93% | -$22.4M | ﹤0.01% | 1612 |
|
|
2021
Q3 | $25.6M | Buy |
282,309
+277,393
| +5,643% | +$21.4M | 0.01% | 807 |
|
|
2021
Q2 | $395K | Buy |
4,916
+1,041
| +27% | +$78.9K | ﹤0.01% | 2951 |
|
|
2021
Q1 | $278K | Sell |
3,875
-94,610
| -96% | -$8.73M | ﹤0.01% | 2964 |
|
|
2020
Q4 | $8.84M | Sell |
98,485
-15,950
| -14% | -$2.36M | 0.01% | 1082 |
|
|
2020
Q3 | $16M | Buy |
114,435
+25,000
| +28% | +$3.8M | 0.01% | 669 |
|
|
2020
Q2 | $15.2M | Buy |
89,435
+85,405
| +2,119% | +$11.6M | 0.01% | 676 |
|
|
2020
Q1 | $387K | Sell |
4,030
-24,469
| -86% | -$2.8M | ﹤0.01% | 2092 |
|
|
2019
Q4 | $3.68M | Sell |
28,499
-76
| -0.3% | -$7.67K | ﹤0.01% | 1533 |
|
|
2019
Q3 | $2.15M | Sell |
28,575
-29,239
| -51% | -$3.45M | ﹤0.01% | 1639 |
|
|
2019
Q2 | $8.79M | Sell |
57,814
-10,767
| -16% | -$1.31M | 0.01% | 949 |
|
|
2019
Q1 | $8.17M | Sell |
68,581
-82,554
| -55% | -$10.6M | 0.01% | 934 |
|
|
2018
Q4 | $16.5M | Buy |
151,135
+51,859
| +52% | +$6.49M | 0.02% | 617 |
|
|
2018
Q3 | $16M | Sell |
99,276
-8,657
| -8% | -$1.18M | 0.01% | 738 |
|
|
2018
Q2 | $14.3M | Buy |
107,933
+42,982
| +66% | +$4.05M | 0.01% | 733 |
|
|
2018
Q1 | $4.81M | Sell |
64,951
-20,756
| -24% | -$1.38M | ﹤0.01% | 1160 |
|
|
2017
Q4 | $4.77M | Buy |
85,707
+1,103
| +1% | +$58.4K | ﹤0.01% | 1146 |
|
|
2017
Q3 | $3.84M | Sell |
84,604
-14,171
| -14% | -$566K | ﹤0.01% | 1281 |
|
|
2017
Q2 | $3.33M | Hold |
98,775
| – | – | ﹤0.01% | 1362 |
|
|
2017
Q1 | $2.92M | Buy |
98,775
+996
| +1% | +$30.8K | ﹤0.01% | 1323 |
|
|
2016
Q4 | $3.35M | Sell |
97,779
-62,581
| -39% | -$2.51M | ﹤0.01% | 1257 |
|
|
2016
Q3 | $9.85M | Sell |
160,360
-100,941
| -39% | -$3.05M | 0.01% | 816 |
|
|
2016
Q2 | $4.98M | Buy |
261,301
+239,179
| +1,081% | +$4.43M | 0.01% | 1103 |
|
|
2016
Q1 | $432K | Buy |
22,122
+21,466
| +3,272% | +$375K | ﹤0.01% | 2106 |
|
|
2015
Q4 | $24K | Buy |
656
+141
| +27% | +$4.57K | ﹤0.01% | 3332 |
|
|
2015
Q3 | $16K | Hold |
515
| – | – | ﹤0.01% | 3330 |
|
|
2015
Q2 | $16K | Buy |
515
+100
| +24% | +$2.04K | ﹤0.01% | 3371 |
|
|
2015
Q1 | $5K | Hold |
415
| – | – | ﹤0.01% | 3637 |
|
|
2014
Q4 | $6K | Buy |
415
+249
| +150% | +$4.22K | ﹤0.01% | 3668 |
|
|
2014
Q3 | $4K | Sell |
166
-940
| -85% | -$21.2K | ﹤0.01% | 3836 |
|
|
2014
Q2 | $33K | Buy |
1,106
+940
| +566% | +$29.7K | ﹤0.01% | 3379 |
|
|
2014
Q1 | $4K | Sell |
166
-100
| -38% | -$2.55K | ﹤0.01% | 3833 |
|
|
2013
Q4 | $5K | Hold |
266
| – | – | ﹤0.01% | 3542 |
|
|
2013
Q3 | $13K | Buy |
266
+100
| +60% | +$3.85K | ﹤0.01% | 3353 |
|
|
2013
Q2 | $6K | Buy |
+166
| New | +$5.94K | ﹤0.01% | 3411 |
|
Other funds holding SRPT
EAM
Bank of Montreal's SRPT Position: Q2 2026 in Review
Bank of Montreal reduced its Sarepta Therapeutics (SRPT) stake by 61% in Q2 2026, selling an estimated $296K and leaving 10,185 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.
Bank of Montreal first reported a position in SRPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.8M in Q1 2022. 298 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Bank of Montreal held 10,185 shares of Sarepta Therapeutics worth $183K as of Q2 2026.
- Bank of Montreal sold 15,630 Sarepta Therapeutics shares in Q2 2026, an estimated $296K.
- Sarepta Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3042 holding.
- Bank of Montreal first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Sarepta Therapeutics position peaked at $37.8M in Q1 2022.
- 298 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.